
HeartBeam fell 75.4% from $1.67 to $0.41, behind the S&P 500's +11.2%. Its worst day was Nov 21 (−53.5%), and its low came Sep 25 at $0.36.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.15 beat the $-0.16 estimate on $0.00 revenue (est. $1.3M).
−0.6% · S&P 500 0.0%
Story events cover the past 12 months · Times ET
Company engaging in multiple options for a constructive resolutionStrategy is underpinned by a clinical study that achieved the agreed upon endpointsCompany believes that labeling modifications can address any
+27.5% · S&P 500 +0.5%
HeartBeam closed at its highest level of the year, 106.0% above where the year started.
+30.8% · S&P 500 −0.3%
EPS of $-0.14 missed the $-0.13 estimate on $0.00 revenue (est. $200,000.00).
−7.5% · S&P 500 −0.6%
HeartBeam shares fell 26.2%, while the S&P 500 rose 0.8%.
−26.2% · S&P 500 +0.8%
EPS of $-0.12 beat the $-0.14 estimate on $0.00 revenue (est. $139,800.00).
+3.0% · S&P 500 +0.8%
EPS of $-0.10 missed the $-0.09 estimate on $0.00 revenue (est. $76,000.00).
−15.3% · S&P 500 −0.2%
HeartBeam closed at its lowest level of the year, 78.5% below where the year started.
−5.1% · S&P 500 +0.5%
The designation recognizes the potential of HeartBeam’s 3D ECG technology, which captures the heart’s electrical signals from three non-coplanar dimensions, to enable physicians to evaluate signs of a possible heart
+50.5%, on 404M shares, the year's heaviest volume · S&P 500 +0.7%
HeartBeam shares rose 32.8%, while the S&P 500 rose 0.3%.
+32.8% · S&P 500 +0.3%
Where it ended: a close of $0.41 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 12, 2026 (EPS est. $-0.09, revenue est. $68,000.00).
Nothing in the past 12 months.
All BEAT dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BEAT and SPY from Benzinga historical bars. Not investment advice.